Systematic Analysis of the Therapy Resistance Genes and Their Prognostic Relevance in Cervical Cancer.
Sangavi EswaranMythili PadavuDileep KumarShama Prasada KabekkoduPublished in: Current pharmaceutical design (2023)
Our thorough investigation uncovered several novel genes and pathways that might contribute to therapy resistance in CC. The genes identified in our study may serve as a biomarker, prognostic indicator, and therapeutic target in CC.